Patents by Inventor Kurt C. Gish

Kurt C. Gish has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods for using chemokine teck
    Patent number: 7276238
    Abstract: Novel chemokines from mammals, reagents related thereto including purified proteins, specific antibodies, and nucleic acids encoding said chemokines. Chemokine receptors are also provided. Methods of using said reagents and diagnostic kits are also provided.
    Type: Grant
    Filed: January 16, 2004
    Date of Patent: October 2, 2007
    Assignee: Schering Corporation
    Inventors: Wei Wang, Kurt C. Gish, Thomas J. Schall, Alain Vicari, Albert Zlotnik
  • Methods of diagnosis of ovarian cancer, compositions and methods of screening for modulators of ovarian cancer
    Patent number: 7189507
    Abstract: Described herein are genes whose expression are up-regulated or down-regulated in ovarian cancer. Related methods and compositions that can be used for diagnosis and treatment of ovarian cancer are disclosed. Also described herein are methods that can be used to identify modulators of ovarian cancer.
    Type: Grant
    Filed: June 17, 2002
    Date of Patent: March 13, 2007
    Assignee: PDL BioPharma, Inc.
    Inventors: David H. Mack, Kurt C. Gish
  • Methods of detecting colorectal cancer
    Publication number: 20040241710
    Abstract: The present invention provides a method of detecting colorectal cancer in a human individual. The method comprises detecting one or more colorectal cancer-associated protein in an extracellular biological sample obtained from a human individual, wherein the presence of colorectal cancer-associated protein in said extracellular biological sample indicates colorectal cancer in said human individual. Preferred colorectal cancer-associated protein is CVA7 or CBF9. Also described herein are methods that can be used to screen candidate bioactive agents for the ability to modulate colorectal cancer. Additionally, methods and molecular targets (genes and their products) for therapeutic intervention in colorectal and other cancers are described.
    Type: Application
    Filed: November 4, 2003
    Publication date: December 2, 2004
    Inventors: Kurt C. Gish, David H. Mack, Keith E. Wilson, Sanford David Markowitz
  • Methods of diagnosis of cancer, compositions and methods of screening for modulators of cancer
    Publication number: 20040219579
    Abstract: Described herein are genes whose expression are up-regulated or down-regulated in specific cancers or other diseases, or are otherwise regulated in disease. Related methods and compositions that can be used for diagnosis, prognosis, and treatment of those medical conditions are disclosed. Also described herein are methods that can be used to identify modulators of these selected conditions.
    Type: Application
    Filed: February 19, 2004
    Publication date: November 4, 2004
    Inventors: Natasha Aziz, Kurt C. Gish, Keith E. Wilson, Albert Zlotnik
  • Methods of diagnosing breast cancer
    Patent number: 6780586
    Abstract: Described herein are methods that can be used for diagnosis and prognosis of breast cancer. Also described herein are methods that can be used to screen candidate bioactive agents for the ability to modulate breast cancer. Additionally, methods and molecular targets (genes and their products) for therapeutic intervention in breast cancer are described.
    Type: Grant
    Filed: October 30, 2000
    Date of Patent: August 24, 2004
    Assignee: Protein Design Labs, Inc.
    Inventors: Kurt C. Gish, David Mack
  • Methods of diagnosing of colorectal cancer, compositions, and methods of screening for colorectal cancer modulators
    Patent number: 6773878
    Abstract: Described herein are methods that can be used for diagnosis and prognosis of colorectal cancer. Also described herein are methods that can be used to screen candidate bioactive agents for the ability to modulate colorectal cancer. Additionally, methods and molecular targets (genes and their products) for therapeutic intervention in colorectal and other cancers are described.
    Type: Grant
    Filed: November 9, 1999
    Date of Patent: August 10, 2004
    Assignee: Eos Biotechnology, Inc.
    Inventors: David Mack, Kurt C. Gish, Keith E. Wilson
  • Methods of diagnosis of breast cancer, compositions and methods of screening for modulators of breast cancer
    Publication number: 20040146862
    Abstract: Described herein are genes whose expression are up-regulated or down-regulated in breast cancer. Also described are such genes whose expression is further up-regulated or down-regulated in drug-resistant breast cancer cells. Related methods and compositions that can be used for diagnosis and treatment of breast cancer are disclosed. Also described herein are methods that can be used to identify modulators of breast cancer.
    Type: Application
    Filed: April 9, 2001
    Publication date: July 29, 2004
    Applicant: EOS Biotechnology, Inc.
    Inventors: David H. Mack, Kurt C. Gish
  • Compositions against cancer antigen LIV-1 and uses thereof
    Publication number: 20040141983
    Abstract: Described herein are methods and compositions that can be used for diagnosis and treatment of cancer.
    Type: Application
    Filed: January 29, 2004
    Publication date: July 22, 2004
    Applicant: Protein Design Labs, Inc.
    Inventors: Debbie Law, Kurt C. Gish, Richard Murray, Patricia Culp
  • Chemokine TECK polypeptides
    Publication number: 20040137578
    Abstract: Novel chemokines from mammals, reagents related thereto including purified proteins, specific antibodies, and nucleic acids encoding said chemokines. Chemokine receptors are also provided. Methods of using said reagents and diagnostic kits are also provided.
    Type: Application
    Filed: January 9, 2004
    Publication date: July 15, 2004
    Inventors: Wei Wang, Kurt C. Gish, Thomas J. Schall, Alain Vicari, Albert Zlotnik
  • Methods of diagnosing breast cancer
    Patent number: 6762020
    Abstract: Described herein are methods that can be used for diagnosis and prognosis of breast cancer. Also described herein are methods that can be used to screen candidate bioactive agents for the ability to modulate breast cancer. Additionally, methods and molecular targets (genes and their products) for therapeutic intervention in breast cancer are described.
    Type: Grant
    Filed: August 18, 2000
    Date of Patent: July 13, 2004
    Assignee: Protein Design Labs, Inc.
    Inventors: David H. Mack, Kurt C. Gish
  • Methods for detection and diagnosing of breast cancer
    Patent number: 6750013
    Abstract: Described herein are methods that can be used for diagnosis and prognosis of breast cancer. Also described herein are methods that can be used to screen candidate bioactive agents for the ability to modulate breast cancer. Additionally, methods and molecular targets (genes and their products) for therapeutic intervention in breast cancer are described.
    Type: Grant
    Filed: December 21, 2000
    Date of Patent: June 15, 2004
    Assignee: Protein Design Labs, Inc.
    Inventors: Kurt C. Gish, David Mack
  • Antibodies that bind chemokine teck
    Patent number: 6723520
    Abstract: Novel chemokines from mammals, reagents related thereto including purified proteins, specific antibodies, and nucleic acids encoding said chemokines. Chemokine receptors are also provided. Methods of using said reagents and diagnostic kits are also provided.
    Type: Grant
    Filed: January 3, 2002
    Date of Patent: April 20, 2004
    Assignee: Schering Corporation
    Inventors: Wei Wang, Kurt C. Gish, Thomas J. Schall, Alain Vicari, Albert Zlotnik
  • Methods of diagnosis of breast cancer, compositions and methods of screening for modulators of breast cancer
    Publication number: 20040029114
    Abstract: Described herein are genes whose expression are up-regulated or down-regulated in breast cancer. Related methods and compositions that can be used for diagnosis and treatment of breast cancer are disclosed. Also described herein are methods that can be used to identify modulators of breast cancer.
    Type: Application
    Filed: January 24, 2002
    Publication date: February 12, 2004
    Applicant: Eos Technology, Inc.
    Inventors: David H. Mack, Kurt C. Gish, Daniel Afar
  • Methods of diagnosing and determining prognosis of colorectal cancer
    Patent number: 6682890
    Abstract: Described herein are methods that can be used for diagnosis and prognosis of colorectal cancer. Also described herein are methods that can be used to screen candidate bioactive agents for the ability to modulate colorectal cancer. Additionally, methods and molecular targets (genes and their products) for therapeutic intervention in colorectal cancer are described.
    Type: Grant
    Filed: May 8, 2001
    Date of Patent: January 27, 2004
    Assignee: Protein Design Labs, Inc.
    Inventors: David Mack, Kurt C. Gish, Keith E. Wilson
  • Methods of diagnosis of ovarian cancer, compositions and methods of screening for modulators of ovarian cancer
    Publication number: 20040005563
    Abstract: Described herein are genes whose expression are up-regulated or down-regulated in ovarian cancer. Related methods and compositions that can be used for diagnosis and treatment of ovarian cancer are disclosed. Also described herein are methods that can be used to identify modulators of ovarian cancer.
    Type: Application
    Filed: June 17, 2002
    Publication date: January 8, 2004
    Applicant: Eos Biotechnology, Inc.
    Inventors: David H. Mack, Kurt C. Gish
  • Methods of diagnosis of cancer, compositions and methods of screening for modulators of cancer
    Publication number: 20030232350
    Abstract: Described herein are genes whose expression are up-regulated or down-regulated in specific cancers or other diseases, or are otherwise regulated in disease. Related methods and compositions that can be used for diagnosis, prognosis, and treatment of those medical conditions are disclosed. Also described herein are methods that can be used to identify modulators of these selected conditions.
    Type: Application
    Filed: November 13, 2002
    Publication date: December 18, 2003
    Applicant: Eos Biotechnology, Inc.
    Inventors: Daniel Afar, Natasha Aziz, Wendy M. Ginsburg, Kurt C. Gish, Richard Glynne, Peter A. Hevezi, David H. Mack, Richard Murray, Susan R. Watson, Keith E. Wilson, Albert Zlotnik
  • Methods of diagnosing breast cancer, compositions, and methods of screening for breast cancer modulators
    Patent number: 6649342
    Abstract: Described herein are methods that can be used for diagnosis and prognosis of breast cancer. Also described herein are methods that can be used to screen candidate bioactive agents for the ability to modulate breast cancer. Additionally, methods and molecular targets (genes and their products) for therapeutic intervention in breast cancer are described.
    Type: Grant
    Filed: September 8, 2000
    Date of Patent: November 18, 2003
    Assignee: Eos Biotechnology, Inc.
    Inventors: David Mack, Kurt C. Gish
  • Novel methods of diagnosing colorectal cancer and/or breast cancer, compositions, and methods of screening for colorectal cancer and/or breast cancer modulators
    Publication number: 20030198951
    Abstract: Described herein are methods that can be used for diagnosis and prognosis of breast and/or colorectal cancer. Also described herein are methods that can be used to screen candidate bioactive agents for the ability to modulate breast and/or colorectal cancer. Additionally, methods and molecular targets (genes and their products) for therapeutic intervention in breast and/or colorectal cancer are described.
    Type: Application
    Filed: December 8, 2000
    Publication date: October 23, 2003
    Inventors: David Mack, Kurt C. Gish, Keith E. Wilson
  • Novel methods of diagnosing breast cancer, compositions, and methods of screening for breast cancer modulators
    Publication number: 20030157544
    Abstract: Described herein are methods that can be used for diagnosis and prognosis of breast cancer. Also described herein are methods that can be used to screen candidate bioactive agents for the ability to modulate breast cancer. Additionally, methods and molecular targets (genes and their products) for therapeutic intervention in breast cancer are described.
    Type: Application
    Filed: February 12, 2003
    Publication date: August 21, 2003
    Applicant: Eos biotechnology, Inc.
    Inventors: Kurt C. Gish, David Mack
  • Methods of diagnosis of ovarian cancer, compositions and methods of screening for modulators of ovarian cancer
    Publication number: 20030124579
    Abstract: Described herein are genes whose expression are up-regulated or down-regulated in ovarian cancer. Related methods and compositions that can be used for diagnosis and treatment of ovarian cancer are disclosed. Also described herein are methods that can be used to identify modulators of ovarian cancer.
    Type: Application
    Filed: September 4, 2002
    Publication date: July 3, 2003
    Applicant: Eos Biotechnology, Inc.
    Inventors: David H. Mack, Kurt C. Gish